Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000258457

Medchemexpress LLC Cdk9-in-13 (compound 38) | 2768712-71-4 | MFCD11162707 | 99.9% | C27H35N5O2 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13998010MG

Encompass_Preferred

CDK9-IN-13 is a research small-molecule inhibitor selective for cyclin-dependent kinase 9 (CDK9). Reported as compound 38, it inhibits CDK9 with an IC50 of <3 nM and has been characterized in preclinical rodent studies where it exhibits short in vivo half-lives. Intended for in vitro and early preclinical research use only.

  • Potent CDK9 inhibition with IC50 <3 nM.
  • Selective activity toward CDK9 for target validation studies.
  • High supplied purity (≈99.94%), limiting impurity-related variability.
  • Defined molecular properties (C27H35N5O2; MW 461.60 g·mol⁻1).
  • Offered in multiple small-scale quantities suitable for preclinical experiments.

Catalog No. 50-002-58457


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.